Business
BioSpectrum Asia
Lunit accelerates AI-powered medical imaging across major overseas channels
South Korea-based startup Lunit has signed a global distribution agreement with Indian firm CARPL.ai, an end-to-end healthcare technology platform that enables the development, validation, and deployment of artificial intelligence (AI) solutions across clinical workflows.
1 min |
December 2022
BioSpectrum Asia
Qmed Asia eyes APAC expansion with digital health solutions
Malaysian startup Qmed Asia has announced regional expansion into Taiwan, Indonesia, Vietnam, and Cambodia to introduce value-added services to healthcare segments and patients in the form of innovative digital health solutions that are accessible, affordable, and reliable.
1 min |
December 2022
BioSpectrum Asia
RVAC Medicines, A*STAR to build capabilities for mRNA production in Singapore
RVAC Medicines, a messenger RNA (mRNA) technology platform startup incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency for Science, Technology and Research (A*STAR) have announced the signing of a master research collaboration agreement to jointly study and develop solutions to build mRNA manufacturing and analytics capabilities in Singapore.
1 min |
December 2022
BioSpectrum Asia
ANDHealth, LaunchVic launch Digital Health Accelerator in Australia
ANDHealth, Australia’s leading digital health commercialisation organisation, has successfully secured $1.4 million in funding from LaunchVic to establish a novel accelerator programme for high growth potential digital health startups.
1 min |
December 2022
BioSpectrum Asia
MIRXES announces Southeast Asia's first business and clinical advisory programme
MiRXES, a Singapore-headquartered biotechnology startup focused on saving lives and improving health economics and outcomes through RNA-powered disease early detection and precision genomic tests, has launched the first edition of MiRXES Translator Programme,
1 min |
December 2022
BioSpectrum Asia
Medtronic launches Customer eXperience Center in Singapore
Medtronic plc, a global leader in healthcare technology, has launched the Medtronic Customer eXperience Center (MCXC) in Singapore, leveraging innovative healthcare technologies across extended reality (XR), augmented and virtual realities, and robotics, to connect the global healthcare community from anywhere, at any time.
1 min |
December 2022
BioSpectrum Asia
QPS opens new preclinical research facility in Taiwan
QPS, a global contract research organisation headquartered in the US, has opened a second preclinical research facility in Taipei, Taiwan.
1 min |
December 2022
BioSpectrum Asia
Boston Scientific expands operations in Malaysia
Boston Scientific Corporation, a global leader in medical device technology, has unveiled a new expansion of its operations in Batu Kawan, Penang, Malaysia.
1 min |
December 2022
BioSpectrum Asia
XtalPi, CK Life Sciences announce AIempowered tumour vaccine R&D in China
Chinese firm XtalPi is embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group.
1 min |
December 2022
BioSpectrum Asia
Astellas invests $50M to support gene therapy programmes of Taysha
Japan-based Astellas Pharma Inc. and Taysha Gene Therapies, Inc. have announced a strategic investment to support the advancement of Taysha’s adeno-associated virus (AAV) gene therapy development programmes for the treatment of Rett syndrome and Giant Axonal Neuropathy (GAN).
1 min |
December 2022
BioSpectrum Asia
GSK launches S$44M HPF in Singapore for cancer treatment
The global biopharma company GSK plc has launched a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.
1 min |
December 2022
BioSpectrum Asia
CSIRO partnership helps connect Australian healthcare system
The Australian Digital Health Agency and Australia’s national science agency, Commonwealth Scientific and Industrial Research Organisation (CSIRO)’s
1 min |
December 2022
BioSpectrum Asia
New Zealand provides snapshot of nation's health with new survey results
The annual New Zealand Health Survey results provide valuable information about the health and wellbeing of New Zealanders.
1 min |
December 2022
BioSpectrum Asia
Brunei's Ministry of Health opens intelligence hub in Jerudong
The Ministry of Health (MoH), Brunei Darussalam and Singapore-based EVYD Technology have announced the official opening of the MoH Intelligence Hub at EVYD Campus in Jerudong.
1 min |
December 2022
BioSpectrum Asia
India announces launch of Bengaluru Science & Technology Cluster
Principal Scientific Adviser to the Government of India, Prof. Ajay Sood recently launched Bengaluru Science & Technology Cluster (BeST).
1 min |
December 2022
BioSpectrum Asia
Hugel's Letybo from Korea obtains marketing approval in Australia
Hugel, a South Korea-based medical aesthetics company, has obtained marketing approval for 50 and 100 units of its botulinum toxin called ‘Letybo’ for the indication of glabellar lines from the Therapeutic Goods Administration (TGA) of Australia.
1 min |
December 2022
BioSpectrum Asia
Who Needs Next Gen Vax Tech?
The COVID-19 vaccines were developed in record time. As the novel’ coronavirus mutates, the vaccine makers, too, are adapting by innovating vaccine technologies. Researchers continue to work, aiming for more potent immunity, reduced transmissibility, cheaper manufacturing, easier transport, and mutation-targeted vaccines. The novel vaccine models may facilitate rapid and effective responses to new infectious diseases, allergies, autoimmune conditions, and cancers. Vaccination programmes can be more cost-effective and efficient by achieving global outreach, maintaining vaccine potency, and optimising logistics, thus increasing global preparedness for future pandemics and disease outbreaks. Let’s explore some of the latest advancements in vaccine technology which emerged in the era of COVID-19.
10 min |
November 2022
BioSpectrum Asia
India Unveils Tele Mental Health Assistance And Networking Across States
Establishing a new milestone in the field of mental health on the occasion of World Mental Health Day on October 10, Tele Mental Health Assistance and Networking Across States (Tele-MANAS), an initiative of the Union Ministry of Health & Family Welfare, Government of India, has been launched in the country.
1 min |
November 2022
BioSpectrum Asia
WHO issues new framework to strengthen collaborative action onTB and comorbidities
The World Health Organisation (WHO) is launching a new framework for collaborative action on tuberculosis (TB) and comorbidities to address the limited uptake of collaborative activities to reduce the burden of TB and comorbidities and to support countries in enabling access to peoplecentred care.
1 min |
November 2022
BioSpectrum Asia
Sierra Leone adds HPV jabs to routine immunisation schedule
In a move to protect adolescent girls from cervical cancer, the government of Sierra Leone, in West Africa, has introduced the Human Papilloma Virus (HPV) vaccine to the routine immunisation schedule and launched the start of a campaign to reach 153,991 girls with the vaccine.
1 min |
November 2022
BioSpectrum Asia
Gavi inks agreement with Moderna for COVID-19 vaccine supply to LICs
Gavi, the Vaccine Alliance, has signed an agreement with Moderna related to the supply of COVID-19 vaccines to lower-income countries (LICs) supported by the Gavi COVAX Advance Market Commitment (AMC).
1 min |
November 2022
BioSpectrum Asia
NousQ receives $175K grand prize for paediatric ear tube insertion device
MedTech Innovator, the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry, has announced NousQ as the winner of the 2022 Asia Pacific Accelerator programme.
1 min |
November 2022
BioSpectrum Asia
Pfizer acquires Australian startup ResApp Health for 179 M
US-based Pfizer has acquired University of Queensland (UQ) startup ResApp Health Limited for $179 million. ResApp, an ASX-listed company based in Brisbane, has developed simple and inexpensive smartphone technology that can accurately identify respiratory diseases based on cough analysis.
1 min |
November 2022
BioSpectrum Asia
Deep Bio explores AI support for prostate cancer diagnosis
South Korea-based startup Deep Bio Inc. has announced that it will sign trial purchase agreements with five Korean hospitals for its artificial intelligence (AI)-based prostate cancer diagnosis support software, DeepDx-Prostate Pro, through the Public Procurement Marketplace programme run by the Korean Public Procurement Service (PPS).
1 min |
November 2022
BioSpectrum Asia
Rx Propellant plans Rs 3k Cr investment to build life sciences lab spaces in India
Rx Propellant, an Actis portfolio company and India’s leading life sciences infrastructure and cluster developers, has announced the launch of 9 lakh sq ft of lab spaces in Genome Valley, Hyderabad, India.
1 min |
November 2022
BioSpectrum Asia
Simcere, Almirall ink S492 M deal for treating autoimmune diseases
Simcere Pharmaceutical Group, an innovation and R&D-driven pharmaceutical company, and Almirall S.A, a global biopharmaceutical company focused on skin health; have entered into an exclusive licensing agreement for Simcere’s IL-2 mutant fusion protein (IL-2 mu-Fc) autoimmune drug candidate, SIM0278.
1 min |
November 2022
BioSpectrum Asia
Samsung Biologics unlocks additional capacity for production at newest Plant 4
Samsung Biologics, South Korea-based contract development and manufacturing organisation (CDMO), has announced that its Plant 4, the world’s largest single bio manufacturing plant, has commenced GMP operations in October 2022.
1 min |
November 2022
BioSpectrum Asia
Fujitsu Asia and A*STAR to advance Al-based healthcare & medical technologies
Singapore based Fujitsu Asia Private Limited (FAPL) and the Agency for Science, Technology and Research (A*STAR) have signed a master research collaboration agreement for joint projects to accelerate the R&D of artificial intelligence (AI) and converging technology solutions around healthcare and medical applications.
1 min |
November 2022
BioSpectrum Asia
Biocon out-licences 2 biosimilar assets for commercialisation in Japan
Indian firm Biocon Biologics has entered into a strategic out-licensing agreement with Japanese pharmaceuticals company Yoshindo Inc. for commercialising two of its pipeline biosimilar assets, bUstekinumab and bDenosumab, in the Japanese market.
1 min |
November 2022
BioSpectrum Asia
Telix Pharma adds new PET imaging radiotracers to GE Healthcare’s portfolio
Australia-based Telix Pharmaceutical has announced a collaborative development and reseller agreement with GE Healthcare to supply its investigational positron emission tomography (PET) imaging radiotracers, TLX250CDx (89Zr-DFO-girentuximab), and [18F]-FLac (18F-3-fluoro2-hydroxypropionate) for use in third party clinical research and development activities.
1 min |